EMAIL DETAILS

Julianna and Hunter,

We are looking to set up a call with Ramji to strategize and discuss
potential partnerships and introductions to Bright Pink and or Komen.
Please let us know when you might be available for a call with Ramji.

Best,

John


John DeLoche
*Co-founder and Managing Director*
Rosemont Seneca Technology Partners
333 Bush Street, 21st Floor
San Francisco, CA 94104
office: 415 767 1288
mobile: 415 793 7070

This email communication is privileged and confidential and is intended
only for the individuals or entities named above. Any unauthorized
dissemination of any of the contents of this email is strictly prohibited.
If you are not the intended recipient, please do not read, copy, use or
disclose to others the contents of this communication. Please notify the
sender that you have received this e-mail in error and then delete the
e-mail.


On Thu, May 29, 2014 at 8:34 AM, Ramji Srinivasan <ramji@counsyl.com> wrote:

> Yes- happy to do that.
>
> We are looking to help then close the loop with screening...
>
> http://instagram.com/p/n_EuobuAtY/
>
> ^^ For example, in this shot there is no direct call to action
>
> Sent from my iPhone
>
> On May 29, 2014, at 6:42, John DeLoche <john@rstp.com> wrote:
>
> We know Michael Slaby very well who is on the board there through Julianna
> and Hunter.
>
> We also know the Komen foundation very well (Nancy) and have multiple
> connections to those and other organizations through both of them. Finally,
> Hunter's mom does a bunch of work on the issue through the Biden Breast
> Health Initiative.
>
> Komen might be somewhat territorial vs BrightPink so we should be
> thoughtful about how we approach them.
>
> Perhaps we can set up a call with Julianna and Hunter to discuss?
>
> John DeLoche
> *Co-founder and Managing Director*
> Rosemont Seneca Technology Partners
> 333 Bush Street, 21st Floor
> San Francisco, CA 94104
> office: 415 767 1288
> mobile: 415 793 7070
>
> This email communication is privileged and confidential and is intended
> only for the individuals or entities named above. Any unauthorized
> dissemination of any of the contents of this email is strictly prohibited.
> If you are not the intended recipient, please do not read, copy, use or
> disclose to others the contents of this communication. Please notify the
> sender that you have received this e-mail in error and then delete the
> e-mail.
>